Pure Biologics S.A. (WSE:PUR)

Poland flag Poland · Delayed Price · Currency is PLN
8.64
-0.25 (-2.76%)
May 15, 2025, 4:45 PM CET
16.53%
Market Cap 33.28M
Revenue (ttm) n/a
Net Income (ttm) -6.25M
Shares Out 3.75M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 15,519
Average Volume 38,287
Open 8.62
Previous Close 8.88
Day's Range 8.55 - 8.87
52-Week Range 6.35 - 33.20
Beta 1.59
RSI 33.89
Earnings Date Apr 16, 2025

About Pure Biologics

Pure Biologics S.A., a biopharmaceutical company, engages in the research and development of biological drugs and non-systematic therapies in the field of immuno-oncology, autoimmunology, and rare neurological diseases. It is involved in the production, purification, analysis, and characterization of antibodies and aptamers; and design, development, and validation of assays, as well as conducts research on technology platforms for selecting active molecules. The company offers PureApta, a modular platform for in vitro selection of modified apta... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 51
Stock Exchange Warsaw Stock Exchange
Ticker Symbol PUR
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.